Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT.

BMC Cancer. 2009 Mar 5;9:77. doi: 10.1186/1471-2407-9-77.

2.

Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells.

Bruserud Ø, Ryningen A, Olsnes AM, Stordrange L, Øyan AM, Kalland KH, Gjertsen BT.

Haematologica. 2007 Mar;92(3):332-41.

3.

Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer.

Halvorsen OJ, Rostad K, Øyan AM, Puntervoll H, Bø TH, Stordrange L, Olsen S, Haukaas SA, Hood L, Jonassen I, Kalland KH, Akslen LA.

Clin Cancer Res. 2007 Feb 1;13(3):892-7.

4.

ERG upregulation and related ETS transcription factors in prostate cancer.

Rostad K, Mannelqvist M, Halvorsen OJ, Oyan AM, Bø TH, Stordrange L, Olsen S, Haukaas SA, Lin B, Hood L, Jonassen I, Akslen LA, Kalland KH.

Int J Oncol. 2007 Jan;30(1):19-32.

PMID:
17143509
5.

Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.

Halvorsen OJ, Oyan AM, Bø TH, Olsen S, Rostad K, Haukaas SA, Bakke AM, Marzolf B, Dimitrov K, Stordrange L, Lin B, Jonassen I, Hood L, Akslen LA, Kalland KH.

Int J Oncol. 2005 Feb;26(2):329-36.

PMID:
15645116

Supplemental Content

Loading ...
Support Center